Soft Tissue Sarcoma
Feature Latest Stories
The panelists, Brian Van Tine, MD, PhD; Jonathan Trent, MD, PhD; Andrew Wagner, MD; Shreyaskumar Patel, MD; Robin L. Jones, MD, MRCP; and R. Lor Randall, MD, FACS; review phase III data with eribulin in advanced leiomyosarcoma and adipocytic sarcoma and discuss the potential for combination therapy.
Cixutumumab Plus Temsirolimus Improves PFS and With Encouraging OS for Bone and Soft Tissue SarcomaBy Gary Schwartz, MD, from the Memorial Sloan-Kettering Cancer Center
Read more >>>
Most Popular Right Now